Gilead makes progress in fight against alleged counterfeit HIV drug network
The firm claimed in court that it has found a network responsible for the sale of counterfeit bottles…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Sep 22
The firm claimed in court that it has found a network responsible for the sale of counterfeit bottles…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
28 Sep 22
The collaboration will deploy automation, large-scale genome engineering, and advanced machine learning and artificial intelligence (AI) algorithms for…
28 Sep 22
The phase 3 confirmatory Clarity AD clinical trial of lecanemab also met all key secondary endpoints, while delivering…
27 Sep 22
Tembexa is an oral antiviral approved by the US Food and Drug Administration (FDA) for the treatment of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Sep 22
As per the terms of the agreement, Seagen will be granted an exclusive worldwide license for LAVA-1223 by…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Sep 22
The EC approval follows a positive opinion granted by the European Medicines Agency (EMA)’s Committee for Medicinal Products…
26 Sep 22
The US District Court found both Merck patents regarding sitagliptin to be valid and infringed
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 Sep 22
GSK will obtain exclusive rights to develop and market Tebipenem HBr worldwide, excluding Japan and certain other Asian…
23 Sep 22
The patient dosing with the haemophilia A gene therapy candidate is expected to start in October 2022 in…
22 Sep 22
Retevmo is an oral, selective RET kinase inhibitor, indicated for locally advanced or metastatic solid tumours with a…